Compare BLTE & STWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | STWD |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.2B |
| IPO Year | 2021 | 2009 |
| Metric | BLTE | STWD |
|---|---|---|
| Price | $154.26 | $16.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $198.00 | $20.00 |
| AVG Volume (30 Days) | 197.8K | ★ 3.7M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 10.64% |
| EPS Growth | N/A | ★ 4.55 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $1,844,289,000.00 |
| Revenue This Year | N/A | $283.44 |
| Revenue Next Year | $492.11 | $17.66 |
| P/E Ratio | ★ N/A | $126.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.12 | $16.29 |
| 52 Week High | $200.00 | $20.99 |
| Indicator | BLTE | STWD |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 40.80 |
| Support Level | $148.00 | N/A |
| Resistance Level | $161.28 | $18.59 |
| Average True Range (ATR) | 7.57 | 0.25 |
| MACD | 1.14 | 0.00 |
| Stochastic Oscillator | 74.33 | 16.67 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.